Wegovy medicine interactions: what the evidence says

The gastric-emptying mechanism: what the guidance actually says

The NHS patient-level guidance on semaglutide makes clear that because Wegovy slows gastric emptying, it has the potential to influence the absorption of any oral medicine taken alongside it. This isn't a theoretical concern. The Wegovy SmPC published on the European Medicines Agency's product information and mirrored on the UK eMC identifies this as a pharmacokinetic interaction, meaning it affects the timing of how a drug enters the bloodstream, not necessarily whether it gets there at all. For most medicines, this matters less than it sounds. A modest slowing of absorption doesn't change the total amount absorbed, and for drugs with a wide therapeutic window the clinical impact is small. The picture changes for medicines where timing is everything: anticoagulants, antiepileptics, levothyroxine, and oral hormonal contraceptives all sit in categories where altered absorption curves are worth taking seriously. If you've been Googling this at midnight because you started Wegovy last month and you're now wondering about your other prescriptions, that instinct to check is the right one, and our guide to Wegovy medication interactions is a reasonable starting point, though your prescriber is the only person who can assess your specific combination.

Oral contraceptives: the most specific warning in UK guidance

NHS England's guidance on weight-management injections notes that women on oral contraceptives should have a discussion with their clinical team about contraceptive cover during Wegovy treatment. The concern is that slower gastric emptying might reduce peak plasma concentrations of the pill, particularly in the early weeks of treatment or after a dose increase when the GI effect is most pronounced. It is worth noting this is different from the tirzepatide-specific guidance, which is more prescriptive: for that medicine, NHS guidance recommends adding a barrier method for the first four weeks of treatment and for four weeks after each dose escalation. For semaglutide/Wegovy, the recommendation is more general (discuss your contraception) but the conversation is no less important. Non-oral contraception (the patch, injection, implant, hormonal IUS) sidesteps the absorption question entirely, which is why prescribers often raise these options. If you are relying on oral contraception and are considering Wegovy, bring this up at your consultation rather than waiting to see whether it becomes a problem.

Other medicines that warrant a conversation before you start

Beyond contraceptives, three categories come up consistently in clinical practice. First, medicines with narrow therapeutic windows (levothyroxine for hypothyroidism, warfarin, and certain antiepileptics) where small shifts in absorption timing can have outsized effects. Thyroid function and INR (for warfarin) are routinely monitored in people starting GLP-1 treatment. Second, insulin and other glucose-lowering medicines: starting Wegovy in someone already on insulin or a sulphonylurea increases the risk of hypoglycaemia, and doses of those medicines may need adjustment. The clinical approach to GLP-1 use alongside diabetes medicines is well-established, but it requires active management rather than passive monitoring. Third, medicines taken for a specific time-sensitive purpose, some antibiotics, for instance, where a consistent absorption profile matters. If you'd like a broader look at what semaglutide is and how it works mechanistically, the Wegovy treatment overview on this site covers the pharmacology in plain terms. You can also find up-to-date safety information via the NHS semaglutide medicines page, which summarises known interactions for patients, and via the NHS England weight-management injections guidance for the specific contraceptive and HRT advice.

What to bring to your consultation, and what happens next

The most useful thing you can do before a consultation is write down every medicine, supplement and over-the-counter product you take regularly, including the doses. This includes herbal supplements: St John's Wort, for example, is a known inducer of drug-metabolising enzymes and is flagged in many drug interaction databases. A GPhC-registered Independent Prescriber reviews this list as part of the clinical assessment, not an automated tool, but a trained clinician reading your answers. At nume, that review happens the same day. For people already taking Wegovy through a previous provider and wondering about a specific interaction that has cropped up, the detailed medicines interaction reference on this site goes further, and the frequently asked questions page covers common queries about switching and ongoing clinical support. If a concern arises during treatment, the right first call is to your prescriber or pharmacist, or, for urgent symptoms, NHS 111. You can also report any suspected reactions through the MHRA Yellow Card scheme, which helps regulators monitor safety signals in real-world use. If you'd like to discuss your medication list with our clinical team before starting, the free consultation at our treatment page is the place to begin.